Biomarin Pharmaceutical – Investors and Politicians Who Own It
BMRN, 6 share classes and securities
Investors who own it
7 tracked investors, $1.5B in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
Dodge & CoxQ2 2026 | $849.4M | 0.44% |
Andreas HalvorsenViking Global Investors, Q2 2026 | $435.8M | 1.24% |
David KroinDeep Track Capital, Q2 2026 | $189.3M | 2.75% |
Howard MarksBondOaktree Capital Management, Q2 2026 | $62.4M | 0.87% |
Ray DalioBridgewater Associates, Q2 2026 | $15.7M | 0.06% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $2.8M | 0.13% |
Mario GabelliGAMCO Investors, Q2 2026 | $743.9K | 0.01% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| David Kroin | Added +188% | 3,307,481 |
| Andreas Halvorsen | Added +7.9% | 7,616,563 |
| Dodge & Cox | Added +1.9% | 14,844,930 |
| David Rosen | Sold out | 0 |
| Howard MarksBond | Added +14% | 64,025,000 |
| Ray Dalio | Added +33% | 274,911 |
| Daniel Schneeberger | Added +169% | 49,000 |
| Mario Gabelli | Reduced −1.1% | 13,000 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
| Politician | Action | Traded |
|---|---|---|
Daniel S. GoldmanD-NY · House | Sold$1K–$15K | Mar 6, 2023disclosed Apr 17, 2023 |
Josh GottheimerJointD-NJ · House | Sold$1K–$15K | Oct 18, 2021disclosed Nov 15, 2021 |
Gilbert Ray Cisneros, Jr.D-CA · House | Bought$15K–$50K | Dec 30, 2020disclosed Jan 11, 2021 |
Josh GottheimerJointD-NJ · House | Bought$1K–$15K | Oct 16, 2020disclosed Nov 5, 2020 |
Josh GottheimerJointD-NJ · House | Sold$1K–$15K | Sep 15, 2020disclosed Oct 13, 2020 |
Josh GottheimerJointD-NJ · House | Bought$1K–$15K | Dec 16, 2019disclosed Jan 6, 2020 |
Josh GottheimerJointD-NJ · House | Bought$1K–$15K | Dec 11, 2019disclosed Jan 6, 2020 |